Should you buy Vedanta, PFC, Cummins, Suzlon, Gujarat Gas, other stocks? Here is what brokerages recommend

Here's what Citi, JPMorgan, Macquarie, Morgan Stanley, Nomura, HSBC, Jefferies, and CLSA make of stocks such as Vedanta (VEDL), Power Finance Corporation (PFC), Cummins India (CUMMINSIND), Suzlon Energy (SUZLON), Gujarat Gas Ltd (GUJGASLTD):

Citi has maintained a 'sell' call on Bata India shares with a target of Rs 1,050.

JPMorgan has maintained an 'underweight' rating on Gujarat Gas shares with a target of Rs 457.

While Macquarie has maintained an 'underperform' rating on the stock with a target of Rs 450.

Moreover, Morgan Stanley has maintained an 'overweight' rating with a target of Rs 614.

Citi has maintained a 'sell' call on the Gujarat Gas stock with a target of Rs 500.

Nomura has maintained a 'neutral' rating on Cummins India shares with a target of Rs 3,470.

HSBC has maintained a 'buy' call on Cummins India shares with a target of Rs 3,700.

Nomura has maintained a 'buy' call on Lupin shares with a target of Rs 1,952.

Macquarie has maintained an 'outperform' rating on the Lupin stock with a target of Rs 1,785.

Jefferies has maintained a 'buy' call on PI Industries shares with a target of Rs 4,750.

Jefferies and Nomura have maintained a 'buy' call on Shree Cement shares with targets of Rs 30,300 and Rs 33,400, respectively.

Morgan Stanley has maintained an 'underweight' rating on the Shree Cement stock with a target of Rs 27,000.

Macquarie has maintained a 'neutral' rating on Shree Cement with a target of Rs 27,034.

CLSA and Bernstein have maintained an 'outperform' rating on Power Finance Corporation (PFC) shares with targets of Rs 610 and Rs 620, respectively.

JPMorgan has maintained a 'neutral' rating on Vedanta shares with a target of Rs 410.

CLSA has maintained an 'outperform' rating on the Vedanta stock with a target of Rs 520.

Jefferies has a 'buy' call on Gland Pharma shares with a target of Rs 2,180. While Citi, on the other hand, has maintained a 'sell' call on the stock with a target of Rs 1,310.

Nomura has maintained a 'neutral' rating on the Gland Pharma stock with a target of Rs 1,570.

Jefferies has maintained a 'buy' call on PB Fintech (PolicyBazaar) shares with a target of Rs 1,500.

Morgan Stanley has maintained an 'equal-weight' rating on PolicyBazaar shares with a target of Rs 1,125.

Morgan Stanley has maintained an 'overweight' rating on Suzlon shares with a target of Rs 73.

Disclaimer: The views/suggestions/recommendations expressed here in this article are solely by investment experts. Zee Business suggests its readers consult their investment advisers before making any financial decision.